Država: Kanada
Jezik: angleščina
Source: Health Canada
SODIUM FLUORIDE F 18
ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS LTD.
V09IX04
FLUDEOXYGLUCOSE (18F)
7400MBq
SOLUTION
SODIUM FLUORIDE F 18 7400MBq
INTRAVENOUS
30ML
Schedule C
ROENTGENOGRAPHY
Active ingredient group (AIG) number: 0153703002; AHFS:
APPROVED
2017-05-10
PRODUCT MONOGRAPH NaF Plus Sodium Fluoride [ 18 F] Injection, U.S.P. Parenteral Solution Diagnostic Radiopharmaceutical Isologic Innovative Radiopharmaceuticals Ltd. Date of Approval: 1855 32e Avenue, Lachine, Quebec H8T 3J1 Control # 171576 April 23, 2014 NaF Plus 2 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ......................................................... 3 SUMMARY PRODUCT INFORMATION ................................................................................ 3 DESCRIPTION ........................................................................................................................... 3 INDICATIONS AND CLINICAL USE ..................................................................................... 4 CONTRAINDICATIONS ........................................................................................................... 4 WARNINGS AND PRECAUTIONS ......................................................................................... 4 ADVERSE REACTIONS ........................................................................................................... 5 DRUG INTERACTIONS............................................................................................................ 5 DOSAGE AND ADMINISTRATION ....................................................................................... 6 RADIATION DOSIMETRY ...................................................................................................... 7 OVERDOSAGE .......................................................................................................................... 7 ACTION AND CLINICAL PHARMACOLOGY ...................................................................... 8 STORAGE AND STABILITY ................................................................................................... 8 SPECIAL HANDLING INSTRUCTIONS ................................................................................. 8 DOSAGE FORMS, COMPOSITION AND PACKAGING .................................. Preberite celoten dokument